TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36426568

Group type: EXPERIMENTAL
Intervention: Culturally adapted psychoeducation intervention (CaPE)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 300
Study: 33022718

Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (Conventional treatments by atropine and pralidoxime)
Number of subjects: 33
Study: 36201971

Group type: EXPERIMENTAL
Intervention: Lung recruitment associated with positive end-expiratory pressure titration according to the best respiratory system compliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional low-positive end-expiratory pressure strategy
Number of subjects: 0
Study: 33210238

Group type: EXPERIMENTAL
Intervention: Physical activity (greater average number of steps per day)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physical activity (greater average hours of moderate and moderate/vigorous intensity)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Physical activity (greater average daily energy expenditure)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Cardiorespiratory fitness (higher peak maximum VO2)
Number of subjects: 73
Study: 32320894

Group type: EXPERIMENTAL
Intervention: Powered Vascular Stapler (PVS)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Standard of Care (SOC) staplers
Number of subjects: 201
Study: 35283083

Group type: COMPARATOR
Intervention: Placebo (no pregabalin)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Ibuprofen (median usage of 2 tablets of 800 mg)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Oxycodone/acetaminophen (median usage of one-half of a 5/325mg tablet)
Number of subjects: 54
Study: 33549556

Group type: EXPERIMENTAL
Intervention: Spironolactone (25 to 50 mg/day)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 527
Study: 32071130

Group type: EXPERIMENTAL
Intervention: NAVA noninvasive ventilation (NIV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: NIV
Number of subjects: 0
Study: 35315170

Group type: COMPARATOR
Intervention: Screening Alone (SA)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Personalized Feedback and Brief Advice (PFBA)
Number of subjects: 756

Group type: EXPERIMENTAL
Intervention: Electronic Brief Intervention (eBI)
Number of subjects: 756
Study: 35522872

Group type: COMPARATOR
Intervention: Treatment for OA and diabetes mellitus according to international recommendations
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Treatment for OA and diabetes mellitus according to international recommendations + drug alpha-lipoic acid
Number of subjects: 67
Study: 32007365

Group type: EXPERIMENTAL
Intervention: T&R-IC
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: IC/IS technique
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: ring-IC/IS
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: IC/IS
Number of subjects: 902
Study: 33543763

Group type: EXPERIMENTAL
Intervention: VX-150
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 32442353

Group type: EXPERIMENTAL
Intervention: Aluminum chloride paste
Number of subjects: 10

Group type: COMPARATOR
Intervention: Displacement cords
Number of subjects: 10
Study: 36311619

Group type: EXPERIMENTAL
Intervention: EYEBIT training method (smartphone virtual reality-based training), 1 hour per day
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional patching method, 2 hours per day
Number of subjects: 76
Study: 33373478

Group type: EXPERIMENTAL
Intervention: Clear fluids with carbohydrate plus whey protein (CHO-P)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Clear fluids with carbohydrate only (CHO)
Number of subjects: 49
Study: 34879245

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde-based desensitizer (Gluma Desensitizer - GL) applied with self-etch strategy (SEGL)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Glutaraldehyde-based desensitizer (Gluma Desensitizer - GL) applied with etch-and-rinse strategy (ERGL)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No glutaraldehyde-based desensitizer (Control group)
Number of subjects: 55
Study: 33935021

Group type: EXPERIMENTAL
Intervention: Full training program (online and in-person simulation training)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Online training only
Number of subjects: 100

Group type: COMPARATOR
Intervention: No training
Number of subjects: 100
Study: 32694494

Group type: EXPERIMENTAL
Intervention: Total disc replacement (TDR)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Nonoperative treatment (multidisciplinary rehabilitation)
Number of subjects: 126
Study: 35537578

Group type: EXPERIMENTAL
Intervention: Hypofractionated RT (68 Gy/25 fractions)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard fractionation RT (78 Gy/39 fractions)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 96
Study: 32358235

Group type: EXPERIMENTAL
Intervention: Bandage contact lens (BCL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No bandage contact lens
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 32381018

Group type: EXPERIMENTAL
Intervention: Eribulin (1.4 mg/m2 on days 1 and 8) with Tmab (8 mg/kg then 6 mg/kg) and Pmab (840 mg then 420 mg) on day 1 of each 21-day cycle
Number of subjects: 480

Group type: COMPARATOR
Intervention: Taxane (docetaxel 75 mg/m2 on day 1 or paclitaxel 80 mg/m2 on days 1, 8, and 15) with Tmab (8 mg/kg then 6 mg/kg) and Pmab (840 mg then 420 mg) on day 1 of each 21-day cycle
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Eribulin with Tmab and Pmab
Number of subjects: 480

Group type: COMPARATOR
Intervention: Taxane with Tmab and Pmab
Number of subjects: 480
Study: 34180407

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Interferential (IF) stimulation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combined treatment with pulsed ultrasound and IF current (CTPI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 14
Study: 34480960

Group type: EXPERIMENTAL
Intervention: IMRT-SIB (50.4 Gy in 1.8 Gy fractions with a 64.4 Gy SIB to the tumor bed)
Number of subjects: 502

Group type: COMPARATOR
Intervention: 3D-CRT-seqB (50.4 Gy in 1.8 Gy fractions followed by a sequential boost of 16 Gy in 2 Gy fractions)
Number of subjects: 502
Study: 34519344

Group type: EXPERIMENTAL
Intervention: Biannual MDA
Number of subjects: 64

Group type: COMPARATOR
Intervention: Annual MDA after peak of transmission
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard MDA combined with snail control
Number of subjects: 64

Group type: COMPARATOR
Intervention: Annual MDA before peak of transmission (standard strategy)
Number of subjects: 64
Study: 34458106

Group type: EXPERIMENTAL
Intervention: Listening to negative news about COVID-19
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Listening to positive news about COVID-19
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Relaxation pause activity after listening to news
Number of subjects: 245
Study: 35322672

Group type: COMPARATOR
Intervention: GALACTIC-HF–ineligible cohort not taking guideline-directed medical therapy (GDMT)
Number of subjects: 9770

Group type: COMPARATOR
Intervention: GALACTIC-HF–eligible cohort with EF ≤28%
Number of subjects: 9770

Group type: COMPARATOR
Intervention: GALACTIC-HF–eligible cohort with EF 29% to 35%
Number of subjects: 9770

Group type: COMPARATOR
Intervention: GALACTIC-HF–eligible cohorts
Number of subjects: 9770
Study: 616982967

Group type: EXPERIMENTAL
Intervention: Foam Rolling (FR)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Running (RR)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Passive Recovery (PR)
Number of subjects: 12
Study: 35610738

Group type: EXPERIMENTAL
Intervention: Fresh Frozen Plasma (FFP) resuscitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no FFP resuscitation)
Number of subjects: 0
Study: 32323020

Group type: EXPERIMENTAL
Intervention: Maternal physiological stress (hair cortisol)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Child physiological stress (hair cortisol)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Economic and psychosocial adversity
Number of subjects: 603
Study: 34736874

Group type: EXPERIMENTAL
Intervention: Lavender essential oil
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rosemary essential oil
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Orange essential oil
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 32041634

Group type: EXPERIMENTAL
Intervention: New child food package for 4 years
Number of subjects: 74871

Group type: COMPARATOR
Intervention: New child food package for < 4 years
Number of subjects: 74871
Study: 35705334

Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs) with risk factor modification (RFM)
Number of subjects: 202

Group type: COMPARATOR
Intervention: RFM+AAD
Number of subjects: 202
Study: 34774400

Group type: EXPERIMENTAL
Intervention: NATURE technique (Nerves And Transversalis-fascia Using RopivacainE)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (local anaesthesia only over surgical incisions)
Number of subjects: 97
Study: 32077321

Group type: EXPERIMENTAL
Intervention: Interpersonal conflict cognitive reappraisal intervention (neutral third-party perspective)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control condition (writing about their day)
Number of subjects: 260
Study: 34895712

Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA) 1 g (10 mL)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Normal saline (NS) (10 mL)
Number of subjects: 121
Study: 34859955

Group type: EXPERIMENTAL
Intervention: Garadacimab (0.1, 0.3, 1, 3, and 10 mg/kg i.v. and 1, 3, and 10 mg/kg s.c.)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Garadacimab (3 and 10 mg/kg i.v. and s.c.)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Garadacimab (single-dose i.v. and s.c.)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Garadacimab
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 34569981

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (30 minutes of treadmill exercise at moderate to high intensity)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Resting control condition
Number of subjects: 20
Study: 36056396

Group type: EXPERIMENTAL
Intervention: Resistance training (RT) program (60 min/session; 3 times/week, for 6 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard clinical follow-up (non-exercised control group)
Number of subjects: 60
Study: 32503030

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (neonates matched for hours of life who were cooled but unexposed to aminophylline)
Number of subjects: 16
Study: 36069803

Group type: EXPERIMENTAL
Intervention: Ibuprofen (2 × 600‐mg doses)
Number of subjects: 9
Study: 35734717

Group type: EXPERIMENTAL
Intervention: Sigmoid colon vaginoplasty
Number of subjects: 39
Study: 34894070

Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone (0.5 mg/kg/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: High-dose prednisolone (1 mg/kg/d)
Number of subjects: 32
Study: 33215359

Group type: EXPERIMENTAL
Intervention: Excluded/ingroup (ostracism)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Excluded/outgroup (racial discrimination)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Included conditions
Number of subjects: 69

Group type: COMPARATOR
Intervention: Ingroup conditions
Number of subjects: 69
Study: 33054405

Group type: EXPERIMENTAL
Intervention: Isotretinoin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 35606811

Group type: EXPERIMENTAL
Intervention: Integrated supportive program (including face-to-face education, coaching at 1 month, and telephone coaching at 2, 3, 6, and 9 months)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Integrated supportive program
Number of subjects: 79

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 79
Study: 33556321

Group type: EXPERIMENTAL
Intervention: Once-daily tenofovir disoproxil fumarate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32599773

Group type: EXPERIMENTAL
Intervention: Protein with higher Tryptophan/Large Neutral Amino Acids (LNAAs) ratio
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Protein with different Tryptophan/Large Neutral Amino Acids (LNAAs) ratios
Number of subjects: 48
Study: 33930239

Group type: EXPERIMENTAL
Intervention: 3D-FLAIR
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: 3D-DIR
Number of subjects: 294

Group type: COMPARATOR
Intervention: 3D-T1
Number of subjects: 294

Group type: COMPARATOR
Intervention: 2D-T2
Number of subjects: 294
Study: 35445570

Group type: EXPERIMENTAL
Intervention: Prototype PTB in Gumline mode
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Prototype PTB in Combined mode
Number of subjects: 39

Group type: COMPARATOR
Intervention: Reference PTB
Number of subjects: 39

Group type: COMPARATOR
Intervention: Reference MTB
Number of subjects: 39
Study: 32811531

Group type: EXPERIMENTAL
Intervention: hUC-MSC treatment group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 0
Study: 34762989

Group type: EXPERIMENTAL
Intervention: Calcium silicate/fluoride toothpaste slurry
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fluoride-only toothpaste slurry
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no fluoride)
Number of subjects: 60
Study: 33407780

Group type: EXPERIMENTAL
Intervention: SPIRIT-AI and CONSORT-AI guidelines
Number of subjects: 0
Study: 35409267

Group type: EXPERIMENTAL
Intervention: HH30 (30 min hypobaric hypoxia)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HH60 (60 min hypobaric hypoxia)
Number of subjects: 80

Group type: COMPARATOR
Intervention: GC30 (30 min ground control)
Number of subjects: 80
Study: 33727278

Group type: EXPERIMENTAL
Intervention: group sessions
Number of subjects: 621

Group type: EXPERIMENTAL
Intervention: combined groups and home visits
Number of subjects: 621

Group type: COMPARATOR
Intervention: control arm
Number of subjects: 621
Study: 34524033

Group type: EXPERIMENTAL
Intervention: Insulin Pump
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Any technology (pump or CGM)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Blood Glucose Monitoring (BGM)
Number of subjects: 165
Study: 32955948

Group type: EXPERIMENTAL
Intervention: 2GETHER program (relationship education and HIV prevention)
Number of subjects: 838
Study: 32801301

Group type: EXPERIMENTAL
Intervention: Nutrition education principles assessment
Number of subjects: 108
Study: 36202024

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Guided Imagery (GI)
Number of subjects: 50
Study: 33793299

Group type: EXPERIMENTAL
Intervention: Palbociclib 125 mg once daily for 13 cycles in addition to endocrine therapy (ET)
Number of subjects: 1250

Group type: COMPARATOR
Intervention: Placebo for 13 cycles in addition to endocrine therapy (ET)
Number of subjects: 1250
Study: 32396510

Group type: EXPERIMENTAL
Intervention: Intramedullar osteosynthesis using elastic stable intramedullary nailing (ESIN)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plate osteosynthesis
Number of subjects: 60
Study: 35868713

Group type: EXPERIMENTAL
Intervention: HMD group
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (non-HMD)
Number of subjects: 39
Study: 32212829

Group type: EXPERIMENTAL
Intervention: CSEMSs
Number of subjects: 66

Group type: COMPARATOR
Intervention: USEMSs
Number of subjects: 66
Study: 34041608

Group type: EXPERIMENTAL
Intervention: Hybrid hyrax appliance with miniscrews
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional hyrax expander with miniscrews
Number of subjects: 35
Study: 33626934

Group type: EXPERIMENTAL
Intervention: PAL+FUL
Number of subjects: 0
Study: 32521785

Group type: EXPERIMENTAL
Intervention: 12 week peer‐led pain management program (PAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35841363

Group type: EXPERIMENTAL
Intervention: Methotrexate and apremilast combination therapy (Group A)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Methotrexate monotherapy (Group B)
Number of subjects: 64